Supriya Lifescience IPO Subscription Status Day 1: Issue subscribed 2.33 times; retail portion booked 12 times

Supriya Lifescience Initial public offer (IPO) fully subscribed as the issue has been booked 2.33 times at 05:00 pm, as per the BSE. The initial public offer received bids for 3,38,75,982 shares as against reserved 1,45,28,299 shares on offer.  Meanwhile, the retail investors already subscribed to the IPO 11.84 times, while the Non-Institutional Investors bid for 66 per cent shares around the same time.  

The three-day offer of the Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs), Supriya Lifescience IPO that opened on December 16 will close on Monday, December 20, 2021.  

See Zee Business Live TV Streaming Below:

Supriya Lifescience Ltd has fixed a price band of Rs 265-274 per share for its Rs 700-crore initial share-sale.

The bidding for anchor investors on December 15 garnered Rs 315 crore from anchor investors to the company.  

Zee Business Managing Editor Anil Singhvi recommended to apply for this offer. "Apply for big listing gain with long-term objective. This is one such IPO that can double investors' money on the listing day as the management has kept room for listing gain. They have kept the valuations cheaper," said Zee Business Managing Editor.    

Proceeds from the fresh issue will be used for funding capital expenditure requirements, repaying debt and general corporate purposes. About 75 per cent of the issue size has been reserved for qualified institutional buyers (QIBs), 15 per cent for non-institutional investors and the remaining 10 per cent for retail investors.  Investors can bid for a minimum of 54 equity shares and in multiples thereof.  

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs), with a focus on research and development.